CoChat
Sign Up
Cited by 49

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years

Su, Pei-yuan, Hsu, Yu-Chun, Cheng, Yu-fang, Kor, Chew-Teng, Su, Wei-Wen·2019·BMC Gastroenterology
DOI 10.1186/s12876-019-1032-yPMC PMC6610843
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12876-019-1032-y

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The prevalence of gallstones in individuals younger than 50 years with obesity and metabolic syndrome was identical to the prevalence in elderly people who were metabolically healthy and not obese.

    “the prevalence of gallstones in individuals younger than 50 years with obesity and metabolic syndrome was identical to the prevalence of gallstones in elderly people who were metabolically healthy and not obese.”

    From Excess Body Weight and Gallstone Disease (2021) · cites this paper as [15]

    The Conclusions describe the two groups’ gallstone prevalence as equal, supporting the comparison. The Results (Baseline characteristics) give rates of 7.2% and 6.8%, however, so the prevalences were similar rather than numerically identical. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

  • The influence of body weight on gallstones has been suggested to occur independently of age.

    “The influence of body weight on gallstones has also recently been suggested to occur independently of age.”

    From Excess Body Weight and Gallstone Disease (2021) · cites this paper as [15]

    The Results (Baseline characteristics; page unavailable) report higher gallstone rates in certain obesity/metabolic phenotypes in both age groups, and the Discussion reports an association after adjustment for age. But the Results also find a significant interaction by age: the obesity/metabolic phenotypes were significant risk factors only below age 50. The paper therefore supports an association beyond age alone, not an influence that is the same regardless of age. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

  • In a retrospective cross-sectional Asian study, participants younger than 50 years had a higher risk of gallstones (OR = 5.4; 95% CI 2.3-12.7) if they were obese and had features of metabolic syndrome.

    “a retrospective cross-sectional Asian study [15] observed participants younger than 50 years to have a higher risk of gallstones (OR = 5.4; 95% CI 2.3-12.7)if they were obese and showed features of the metabolic syndrome.”

    From Excess Body Weight and Gallstone Disease (2021) · cites this paper as [15]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018;34:81–9. · DOI
  2. Lammert F, Acalovschi M, Ercolani G, et al. EASL clinical practice guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol. 2016;65:146–81. · DOI · Paper page
  3. Lin I-C, Yang Y-W, Wu M-F, et al. The association of metabolic syndrome and its factors with gallstone disease. BMC Fam Pract. 2014;15:138. · DOI
  4. Li X, Guo X, Ji H, Yu G, Gao P. Gallstones in Patients with Chronic Liver Diseases. Biomed Res Int. 2017;2017:9749802.
  5. Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Prim. 2016;2:16024. · DOI · Paper page
  6. Shabanzadeh DM, Skaaby T, Sørensen LT, Eugen-Olsen J, Jørgensen T. Metabolic biomarkers and gallstone disease–a population-based study. Scand J Gastroenterol. 2017;52:1270–7. · DOI
  7. Ahmed F, Baloch Q, Memon ZA, Ali I. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. Ann Med Surg. 2017;17:7–13. · DOI
  8. Zhu Q, Sun X, Ji X, et al. The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. Sci Rep. 2016;6:1–9. · DOI · Paper page
  9. Tsai CH, Wu JS, Chang YF, Lu FH, Yang YC, Chang CJ. The number of metabolic abnormalities associated with the risk of gallstones in a non-diabetic population. PLoS One. 2014;9:1–6.
  10. Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30:1009–19. · DOI
  11. Bonfrate L, DQH W, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol. 2014;28:623–35. · DOI · Paper page
  12. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004;89:2569–75. · DOI
  13. Denis GV, Obin MS. 'Metabolically healthy obesity': origins and implications. Mol Asp Med. 2013;34:59–70. · DOI
  14. Kim TJ, Kim ER, Hong SN, et al. Metabolic unhealthiness is an important predictor for the development of advanced colorectal neoplasia. Sci Rep. 2017;7:9011. · DOI
  15. Luo D, Liu F, Li X, et al. Comparison of the effect of ‘metabolically healthy but obese’ and ‘metabolically abnormal but not obese’ phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine. 2015;49:130–8. · DOI
  16. Hashimoto Y, Tanaka M, Okada H, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10:578–83. · DOI
  17. KGMM A, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international. Circulation. 2009;120:1640–5. · DOI · Paper page
  18. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne: Health Communications Australia; 2000.
  19. Venneman NG, van Erpecum KJ. Pathogenesis of gallstones. Gastroenterol Clin N Am. 2010;39:171–83. · DOI
  20. Chen J-Y, Hsu C-T, Liu J-H, Tung T-H. Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. BMC Gastroenterol. 2014;14:83. · DOI
  21. Denis GV, Obin MS. “Metabolically healthy obesity”: origins and implications. Mol Asp Med. 2013;34:59–70. · DOI
  22. Denis GV, Hamilton JA. Healthy obese persons: how can they be identified and do metabolic profiles stratify risk? Curr Opin Endocrinol Diabetes Obes. 2013;20:369–76. · DOI
  23. Blüher M. Mechanisms in endocrinology: are metabolically healthy obese individuals really healthy? Eur J Endocrinol. 2014;171:R209–19. · DOI
  24. Ryoo JH, Park SK, Ye S, et al. Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men. Endocrine. 2015;50:650–8. · DOI
  25. Shen HC, Hu YC, Chen YF, Tung TH. Prevalence and associated metabolic factors of gallstone disease in the elderly agricultural and fishing population of taiwan. Gastroenterol Res Pract. 2014;2014:876918. · DOI
  26. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin N Am. 2010;39:157–69. · DOI
  27. Lirussi F, Nassuato G, Passera D, et al. Gallstone disease in an elderly population: the Silea study. Eur J Gastroenterol Hepatol. 1999;11:485–91. · DOI
  28. Agrusa A, Romano G, Frazzetta G, et al. Role and outcomes of laparoscopic cholecystectomy in the elderly. Int J Surg. 2014;12:S37–9. · DOI
  29. Magnuson TH, Ratner LE, Zenilman ME, Bender JS. Laparoscopic cholecystectomy: applicability in the geriatric population. Am Surg. 1997;63:91–6.
  30. Li X, Gao P. Hepatitis C virus infection increases risk of gallstone disease in elderly Chinese patients with chronic liver disease. Sci Rep. 2018;8:14–9. · DOI
  31. Wong RJ, Gish RG. Metabolic manifestations and complications associated with chronic hepatitis C virus infection. Gastroenterol Hepatol (NY). 2016;12:293–9.
  32. Stepanova M, Lam B, Younossi Y, Srishord MK, Younossi ZM. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. J Viral Hepat. 2012;19:341–5. · DOI
  33. Acalovschi M, Buzas C, Radu C, Grigorescu M. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. J Viral Hepat. 2009;16:860–6. · DOI
  34. Negro F. HCV infection and metabolic syndrome: which is the chicken and which is the egg? Gastroenterology. 2012;142:1288–92. · DOI

Cited by

Sorted by citations

Metadata

Authors
Su, P.-Y., Hsu, Y.-C., Cheng, Y.-F., Kor, C.-T., & Su, W.-W.
Venue
BMC Gastroenterology
Publisher
Springer Science and Business Media LLC
Published
2019-07-04
Volume
19
Issue
1
ISSN
1471-230X
DOI
10.1186/s12876-019-1032-y
PMC
PMC6610843
Cited by
49
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review